Acquis helps biopharmaceutical, medical device, and digital health companies stand up, build, and operationalize their functions from early development throughout the product lifecycle

Go down

Our Communities of Practice

Our Life Sciences Consulting team delivers tailored solutions for our clients’ most pressing business needs, leveraging best practices across the life sciences industry and beyond

Medical & Clinical

We work across the product development lifecycle to develop and implement medical and clinical operations strategy to help pharmaceuticals, biotechnology, medical technology companies to improve clinical outcomes and tackle unmet medical needs

Commercial

We empower you to achieve results by delivering commercial strategy across the full product lifecycle, ensuring launch readiness for your assets, and driving impactful initiatives to improve business and patient outcomes

Compliance

We help you achieve inspection readiness and navigate the complex regulatory environment post-FDA approval, including Department of Justice Office of the Inspector General requirements and industry best practices

WHY
PARTNER
WITH ACQUIS

Strategic Thought Leadership

  • We pair you with experienced business and life sciences strategy leaders who help guide your decisions, develop robust plans, and prioritize strategic initiatives
Comfortably scale by integrating medical, commercial, and compliance experts

Think + Do

  • We design tailored life sciences strategies for your business and then supports you through implementation
Define your overall medical operations and commercial strategy, capability requirements, timelines, and investment

Comprehensive Service Offerings

  • We partner with you at every and any stage of the life science product lifecycle
Understand your challenges and help to optimize opportunities in your early, late-stage, and commercialized products

The Drug Development Process

The journey of developing a new pharmaceutical product represents one of the most complex, resource-intensive, and high-risk undertakings in modern business. This comprehensive guide examines the drug development process from initial discovery through commercialization, exploring how pharmaceutical innovators balance scientific rigor, regulatory requirements, and commercial strategy to develop new therapeutic options.

Insight

April 2025

AI in Clinical Trials: New Frontiers

The clinical trial landscape is changing, driven by AI technologies that redefine what’s possible in therapeutic development. This revolution extends far beyond simple efficiency gains — AI fundamentally alters how trials are designed, conducted, monitored, and evaluated. Organizations that understand these shifts gain strategic advantages in speed-to-market, research quality, and patient-centricity. 

Case Study

February 2025

Harnessing Data Intelligence to Assess Launch Readiness

Acquis partnered with a pharmaceutical leader to transform complex pre-launch data into actionable insights and evaluate launch readiness.

Insight

November 2024

AI-Accelerated Breakthroughs: How AI is Reshaping the Future of Life Sciences

How AI in Life Sciences is transforming drug development with insights from industry experts on players, ROI, and future trends.

Insight

April 2025

Resource Management for Clinical Operations

To meet the demands of today’s trials, organizations need more than decentralized headcount tracking. They need a centralized, analytics-enabled resource management capability — one that provides full transparency into bandwidth, talent allocation, and strategic priorities across functions. 

Insight

October 2024

Transforming Pharma: Harnessing Artificial Intelligence in the Pharmaceutical Value Chain

The rise of artificial intelligence continues to transform the pharmaceutical industry, offering solutions to longstanding challenges across the value chain. As pharmaceutical companies embrace this technological revolution, organizations are implementing AI use cases that tackle critical issues in drug discovery, clinical trial development, and patient monitoring, opening doors to innovative approaches in pharmaceutical research and development. 

Ebook

April 2022

Launching in a New Therapeutic Area

Ebook

October 2022

Strategic Alliances for Development & Commercialization

A strategic alliance is an opportunity for multiple organizations to enhance drug development and commercialization by leveraging complementary strengths.

Ebook

September 2022

Supplier Diversity

Ebook

January 2023

Driving Diversity, Equity, and Inclusion in Clinical Trials

To ensure equitable healthcare outcomes across diverse populations, it is essential to involve patients from underrepresented communities in clinical research. In addition to reinforcing drug safety, expanding clinical trial diversity can help sponsors to stay on top of FDA and global health authority guidance, and to build patient trust in new treatment modalities.

Insight

April 2022

Post-Merger Integration (PMI) in Life Sciences: Levers for Your Success

Insight

October 2021

The Intersection of Pricing, Reimbursement, and Market Access Strategies

Insight

May 2024

­­­Quantitative Operating Model Design for Life Sciences Organizations in the Era of AI

In recent years, the Life Sciences industry has witnessed a significant transformation due to the convergence of digital innovation and artificial intelligence (AI). The Life Science companies that are best at deploying AI and machine learning to expedite drug discovery, personalize medicine, and make patient-centric decisions will come out significantly ahead over those that do not.

Insight

January 2025

2025: A Cautiously Optimistic Year for Healthcare

The 2025 J.P. Morgan Healthcare Conference signaled steady progress in healthcare and painted a picture of an industry at a turning point.

News

September 2024

Acquis Consulting Group and NyquistAI Partner to Enhance Data and AI Service Offerings for Life Sciences Companies

Acquis Consulting Group, a leading global management consulting firm, and NyquistAI, the leading AI platform for life science intelligence and analytics, today announced their strategic partnership. The partnership aims to streamline insight generation for life sciences organizations through expert advisory services and customized AI-powered solutions. 

Insight

October 2024

Acquis Spotlight Series: Precision Medicine in South Africa

Precision medicine, or personalized medicine, has moved from niche to mainstream. Companies continue to place larger bets on its transformative impact to create unprecedented patient outcomes. While precision medicine offers significant market opportunities, the traditional models for drug development no longer apply, creating new complexities. Precision medicine requires more nuanced clinical trial designs, complex data infrastructure, and novel market access strategies due to its highly targeted therapies and smaller patient populations.

Insight

May 2024

Preparing for the Next Decentralized Clinical Trial Quantum Leap 

The clinical trial landscape is transforming and pivoting away from its reliance on data collection within the confines of traditional research facilities.

Vivian Lee

Managing Director


Vivian leads Acquis’ Life Sciences practice area. She is a natural explorer, driven by curiosity to uncover creative solutions, chart new paths to sustained success, and lead her clients — particularly in the life sciences — toward an innovative future. A strong advocate for partnership and collaboration, she is dedicated to designing solutions centered on the end user —  business or patient. Her focus on understanding individual challenges and processes allows her to deliver customized, impactful results that truly address pain points and needs.

Find out more about